Tapewire

Nasdaq · USD

TARS

Tarsus Pharmaceuticals, Inc.

Export transactions ↓
Tapewire entity
1836
SEC CIK
0001819790
Parsed reports
328

Last 12 months

Inside the activity.

0 purchase rows · 59 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202509
Jan 202604
Feb 202600
Mar 2026026
Apr 202600
May 202600
Jun 202606
Jul 202600
Aug 202600
Sep 2026014
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
September 15, 2026 Filed Sep 17, 2026 20:47 UTC Exercise / conversionRestricted Stock Units · Derivative 201 $0.00 $0.00
Disclosure

SEC source: 0001051578-26-000010 · wk-form4_1789678066.xml · derivative · entry 2

PYOTT DAVID E I · CIK 0001051578 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 605

Underlying: Common Stock · 201 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Company's common stock.

F4 · derivative.exercise_date: RSUs granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2026 annual meeting of stockholders. The RSUs vest in equal installments on 9/15/2026, 12/15/2026, 3/15/2027 and 6/15/2027, subject to the non-employee director's continuous service.

F4 · derivative.expiration_date: RSUs granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2026 annual meeting of stockholders. The RSUs vest in equal installments on 9/15/2026, 12/15/2026, 3/15/2027 and 6/15/2027, subject to the non-employee director's continuous service.

Read SEC document
September 15, 2026 Filed Sep 17, 2026 20:47 UTC Exercise / conversionCommon Stock 201 Not disclosed Not disclosed
Disclosure

SEC source: 0001051578-26-000010 · wk-form4_1789678066.xml · nonDerivative · entry 1

PYOTT DAVID E I · CIK 0001051578 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · By the David E.I. Pyott Trust

Disclosed balance after: 9,575

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: The shares were issued pursuant to settlement of vested Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Company's common stock.

F2 · balance_after: Includes 1,383 shares previously owned directly that were transferred to the reporting person's trust on May 14, 2026. There was no change in the reporting person's pecuniary interest in the shares.

Read SEC document
September 15, 2026 Filed Sep 17, 2026 20:22 UTC Exercise / conversionRestricted Stock Units · Derivative 201 $0.00 $0.00
Disclosure

SEC source: 0001228684-26-000010 · wk-form4_1789676560.xml · derivative · entry 5

LINK WILLIAM J PHD · CIK 0001228684 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 605

Underlying: Common Stock · 201 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Company's common stock.

F6 · derivative.exercise_date: RSUs granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2026 annual meeting of stockholders. The RSUs vest in equal installments on 9/15/2026, 12/15/2026, 3/15/2027 and 6/15/2027, subject to the non-employee director's continuous service.

F6 · derivative.expiration_date: RSUs granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2026 annual meeting of stockholders. The RSUs vest in equal installments on 9/15/2026, 12/15/2026, 3/15/2027 and 6/15/2027, subject to the non-employee director's continuous service.

Read SEC document
September 15, 2026 Filed Sep 17, 2026 20:22 UTC SaleCommon Stock 66 $80.01 $5,280.66
Disclosure

SEC source: 0001228684-26-000010 · wk-form4_1789676560.xml · nonDerivative · entry 4

LINK WILLIAM J PHD · CIK 0001228684 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 94,487

F2 · kind: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 8, 2025.

Read SEC document
September 15, 2026 Filed Sep 17, 2026 20:22 UTC SaleCommon Stock 759 $79.00 $59,961.00
Disclosure

SEC source: 0001228684-26-000010 · wk-form4_1789676560.xml · nonDerivative · entry 3

LINK WILLIAM J PHD · CIK 0001228684 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 94,553

F2 · kind: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 8, 2025.

F4 · price: The price reported in column 4 is a weighted average price. The shares were pooled and sold in multiple transactions at prices ranging from $78.89 to $79.10. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
September 15, 2026 Filed Sep 17, 2026 20:22 UTC SaleCommon Stock 11,675 $78.33 $914,502.75
Disclosure

SEC source: 0001228684-26-000010 · wk-form4_1789676560.xml · nonDerivative · entry 2

LINK WILLIAM J PHD · CIK 0001228684 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 95,312

F2 · kind: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 8, 2025.

F3 · price: The price reported in column 4 is a weighted average price. The shares were pooled and sold in multiple transactions at prices ranging from $77.87 to $78.86. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
September 15, 2026 Filed Sep 17, 2026 20:22 UTC Exercise / conversionCommon Stock 201 Not disclosed Not disclosed
Disclosure

SEC source: 0001228684-26-000010 · wk-form4_1789676560.xml · nonDerivative · entry 1

LINK WILLIAM J PHD · CIK 0001228684 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 106,987

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: The shares were issued pursuant to settlement of vested Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Company's common stock.

Read SEC document
September 15, 2026 Filed Sep 17, 2026 20:22 UTC Exercise / conversionRestricted Stock Units · Derivative 302 $0.00 $0.00
Disclosure

SEC source: 0001181186-26-000008 · wk-form4_1789676577.xml · derivative · entry 2

YARNO WENDY L · CIK 0001181186 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 907

Underlying: Common Stock · 302 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Company's common stock.

F3 · derivative.exercise_date: RSUs granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2026 annual meeting of stockholders. The RSUs vest in equal installments on 9/15/2026, 12/15/2026, 3/15/2027 and 6/15/2027, subject to the non-employee director's continuous service.

F3 · derivative.expiration_date: RSUs granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2026 annual meeting of stockholders. The RSUs vest in equal installments on 9/15/2026, 12/15/2026, 3/15/2027 and 6/15/2027, subject to the non-employee director's continuous service.

Read SEC document
September 15, 2026 Filed Sep 17, 2026 20:22 UTC Exercise / conversionCommon Stock 302 Not disclosed Not disclosed
Disclosure

SEC source: 0001181186-26-000008 · wk-form4_1789676577.xml · nonDerivative · entry 1

YARNO WENDY L · CIK 0001181186 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,956

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: The shares were issued pursuant to settlement of vested Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Company's common stock.

Read SEC document
September 04, 2026 Filed Sep 9, 2026 20:14 UTC
Azamian Bobak R.Director · President/CEO and Board Chair
SaleCommon Stock 2,900 $91.27 $264,683.00
Disclosure

SEC source: 0001827672-26-000013 · wk-form4_1788984881.xml · nonDerivative · entry 2

Azamian Bobak R. · CIK 0001827672 · Director · President/CEO and Board Chair

10b5-1 filing: Plan reported

Ownership: Indirect · By the Bobak Azamian Living Trust established April 16, 2018

Disclosed balance after: 827,991

F1 · kind: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 9, 2025.

F4 · price: The price reported in column 4 is a weighted average price. The shares were pooled and sold in multiple transactions at prices ranging from $91.06 to $91.45. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F3 · ownership.nature: The Reporting Person is the trustee of the Bobak Azamian Living Trust, established April 16, 2018 and has voting and dispositive power with respect to these shares.

Read SEC document
September 04, 2026 Filed Sep 9, 2026 20:14 UTC
Azamian Bobak R.Director · President/CEO and Board Chair
SaleCommon Stock 7,100 $90.27 $640,917.00
Disclosure

SEC source: 0001827672-26-000013 · wk-form4_1788984881.xml · nonDerivative · entry 1

Azamian Bobak R. · CIK 0001827672 · Director · President/CEO and Board Chair

10b5-1 filing: Plan reported

Ownership: Indirect · By the Bobak Azamian Living Trust established April 16, 2018

Disclosed balance after: 830,891

F1 · kind: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 9, 2025.

F2 · price: The price reported in column 4 is a weighted average price. The shares were pooled and sold in multiple transactions at prices ranging from $90.00 to $90.91. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F3 · ownership.nature: The Reporting Person is the trustee of the Bobak Azamian Living Trust, established April 16, 2018 and has voting and dispositive power with respect to these shares.

Read SEC document
September 04, 2026 Filed Sep 9, 2026 20:13 UTC
Lin Elizabeth YeuChief Medical Officer
SaleCommon Stock 1,590 $90.00 $143,100.00
Disclosure

SEC source: 0001842190-26-000011 · wk-form4_1788984804.xml · nonDerivative · entry 4

Lin Elizabeth Yeu · CIK 0001842190 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Indirect · By Spouse's Roth IRA

Disclosed balance after: 1,590

F2 · kind: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 1, 2026.

Read SEC document
September 04, 2026 Filed Sep 9, 2026 20:13 UTC
Lin Elizabeth YeuChief Medical Officer
SaleCommon Stock 1,590 $85.00 $135,150.00
Disclosure

SEC source: 0001842190-26-000011 · wk-form4_1788984804.xml · nonDerivative · entry 3

Lin Elizabeth Yeu · CIK 0001842190 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Indirect · By Spouse's Roth IRA

Disclosed balance after: 3,180

F2 · kind: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 1, 2026.

Read SEC document
September 04, 2026 Filed Sep 9, 2026 20:13 UTC
Lin Elizabeth YeuChief Medical Officer
SaleCommon Stock 5,386 $90.00 $484,740.00
Disclosure

SEC source: 0001842190-26-000011 · wk-form4_1788984804.xml · nonDerivative · entry 2

Lin Elizabeth Yeu · CIK 0001842190 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 2,547

F1 · kind: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 29, 2026.

Read SEC document
September 04, 2026 Filed Sep 9, 2026 20:13 UTC
Lin Elizabeth YeuChief Medical Officer
SaleCommon Stock 5,387 $85.00 $457,895.00
Disclosure

SEC source: 0001842190-26-000011 · wk-form4_1788984804.xml · nonDerivative · entry 1

Lin Elizabeth Yeu · CIK 0001842190 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 7,933

F1 · kind: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 29, 2026.

Read SEC document
September 04, 2026 Filed Sep 9, 2026 20:12 UTC
Neervannan SeshadriChief Operating Officer
SaleCommon Stock 4,564 $85.00 $387,940.00
Disclosure

SEC source: 0001827584-26-000013 · wk-form4_1788984767.xml · nonDerivative · entry 1

Neervannan Seshadri · CIK 0001827584 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 78,532

F1 · kind: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 13, 2025.

F2 · balance_after: Includes 305 shares acquired under the Issuer's Employee Stock Purchase Plan on June 30, 2026.

Read SEC document
September 02, 2026 Filed Sep 3, 2026 20:30 UTC
Azamian Bobak R.Director · President/CEO and Board Chair
SaleCommon Stock 10,000 $80.06 $800,600.00
Disclosure

SEC source: 0001827672-26-000011 · wk-form4_1788467407.xml · nonDerivative · entry 1

Azamian Bobak R. · CIK 0001827672 · Director · President/CEO and Board Chair

10b5-1 filing: Plan reported

Ownership: Indirect · By the Bobak Azamian Living Trust established April 16, 2018

Disclosed balance after: 837,991

F1 · kind: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 9, 2025.

F2 · price: The price reported in column 4 is a weighted average price. The shares were pooled and sold in multiple transactions at prices ranging from $80.00 to $80.20. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F3 · ownership.nature: The Reporting Person is the trustee of the Bobak Azamian Living Trust, established April 16, 2018 and has voting and dispositive power with respect to these shares.

Read SEC document
September 02, 2026 Filed Sep 3, 2026 20:29 UTC
Lin Elizabeth YeuChief Medical Officer
SaleCommon Stock 1,590 $80.00 $127,200.00
Disclosure

SEC source: 0001842190-26-000009 · wk-form4_1788467389.xml · nonDerivative · entry 3

Lin Elizabeth Yeu · CIK 0001842190 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Indirect · By Spouse's Roth IRA

Disclosed balance after: 4,770

F2 · kind: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 1, 2026.

Read SEC document
September 02, 2026 Filed Sep 3, 2026 20:29 UTC
Lin Elizabeth YeuChief Medical Officer
SaleCommon Stock 5,387 $80.00 $430,960.00
Disclosure

SEC source: 0001842190-26-000009 · wk-form4_1788467389.xml · nonDerivative · entry 2

Lin Elizabeth Yeu · CIK 0001842190 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 13,320

F1 · kind: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 29, 2026.

Read SEC document
September 01, 2026 Filed Sep 3, 2026 20:29 UTC
Lin Elizabeth YeuChief Medical Officer
SaleCommon Stock 4,601 $73.86 $339,829.86
Disclosure

SEC source: 0001842190-26-000009 · wk-form4_1788467389.xml · nonDerivative · entry 1

Lin Elizabeth Yeu · CIK 0001842190 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 18,707

F1 · kind: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 29, 2026.

Read SEC document
June 25, 2026 Filed Jun 29, 2026 20:30 UTC GrantRestricted Stock Units · Derivative 806 $0.00 $0.00
Disclosure

SEC source: 0001051578-26-000008 · wk-form4_1782765056.xml · derivative · entry 3

PYOTT DAVID E I · CIK 0001051578 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 806

Underlying: Common Stock · 806 shares

Expires not disclosed

F2 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Company's common stock.

F4 · derivative.exercise_date: RSUs granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2026 annual meeting of stockholders. The RSUs vest in equal installments on 9/15/2026, 12/15/2026, 3/15/2027 and 6/15/2027, subject to the non-employee director's continuous service.

F4 · derivative.expiration_date: RSUs granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2026 annual meeting of stockholders. The RSUs vest in equal installments on 9/15/2026, 12/15/2026, 3/15/2027 and 6/15/2027, subject to the non-employee director's continuous service.

Read SEC document
June 25, 2026 Filed Jun 29, 2026 20:30 UTC GrantRestricted Stock Units · Derivative 2,417 $0.00 $0.00
Disclosure

SEC source: 0001051578-26-000008 · wk-form4_1782765056.xml · derivative · entry 2

PYOTT DAVID E I · CIK 0001051578 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,417

Underlying: Common Stock · 2,417 shares

Expires not disclosed

F2 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Company's common stock.

F3 · derivative.exercise_date: RSUs granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2026 annual meeting of stockholders. The RSUs vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service.

F3 · derivative.expiration_date: RSUs granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2026 annual meeting of stockholders. The RSUs vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service.

Read SEC document
June 25, 2026 Filed Jun 29, 2026 20:30 UTC GrantStock Option (right to buy) · Derivative 3,837 $0.00 Strike: $64.34 $0.00
Disclosure

SEC source: 0001051578-26-000008 · wk-form4_1782765056.xml · derivative · entry 1

PYOTT DAVID E I · CIK 0001051578 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,837

Underlying: Common Stock · 3,837 shares

Expires 2036-06-24

F1 · derivative.exercise_date: Annual option granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2026 annual meeting of stockholders. The option will vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service.

Read SEC document
June 25, 2026 Filed Jun 29, 2026 20:32 UTC GrantRestricted Stock Units · Derivative 2,417 $0.00 $0.00
Disclosure

SEC source: 0002044770-26-000008 · wk-form4_1782765122.xml · derivative · entry 2

Goodrich Katherine · CIK 0002044770 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,417

Underlying: Common Stock · 2,417 shares

Expires not disclosed

F2 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Company's common stock.

F3 · derivative.exercise_date: RSUs granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2026 annual meeting of stockholders. The RSUs vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service.

F3 · derivative.expiration_date: RSUs granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2026 annual meeting of stockholders. The RSUs vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service.

Read SEC document
June 25, 2026 Filed Jun 29, 2026 20:32 UTC GrantStock Option (right to buy) · Derivative 3,837 $0.00 Strike: $64.34 $0.00
Disclosure

SEC source: 0002044770-26-000008 · wk-form4_1782765122.xml · derivative · entry 1

Goodrich Katherine · CIK 0002044770 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,837

Underlying: Common Stock · 3,837 shares

Expires 2036-06-24

F1 · derivative.exercise_date: Annual option granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2026 annual meeting of stockholders. The option will vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service.

Read SEC document
June 25, 2026 Filed Jun 29, 2026 20:31 UTC GrantRestricted Stock Units · Derivative 2,417 $0.00 $0.00
Disclosure

SEC source: 0001827722-26-000004 · wk-form4_1782765110.xml · derivative · entry 2

Goldberg Andrew D. · CIK 0001827722 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,417

Underlying: Common Stock · 2,417 shares

Expires not disclosed

F2 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Company's common stock.

F3 · derivative.exercise_date: RSUs granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2026 annual meeting of stockholders. The RSUs vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service.

F3 · derivative.expiration_date: RSUs granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2026 annual meeting of stockholders. The RSUs vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service.

Read SEC document
June 25, 2026 Filed Jun 29, 2026 20:31 UTC GrantStock Option (right to buy) · Derivative 3,837 $0.00 Strike: $64.34 $0.00
Disclosure

SEC source: 0001827722-26-000004 · wk-form4_1782765110.xml · derivative · entry 1

Goldberg Andrew D. · CIK 0001827722 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,837

Underlying: Common Stock · 3,837 shares

Expires 2036-06-24

F1 · derivative.exercise_date: Annual option granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2026 annual meeting of stockholders. The option will vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service.

Read SEC document
June 25, 2026 Filed Jun 29, 2026 20:31 UTC GrantRestricted Stock Units · Derivative 2,417 $0.00 $0.00
Disclosure

SEC source: 0001662426-26-000006 · wk-form4_1782765098.xml · derivative · entry 2

Morrison Scott W · CIK 0001662426 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,417

Underlying: Common Stock · 2,417 shares

Expires not disclosed

F2 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Company's common stock.

F3 · derivative.exercise_date: RSUs granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2026 annual meeting of stockholders. The RSUs vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service.

F3 · derivative.expiration_date: RSUs granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2026 annual meeting of stockholders. The RSUs vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service.

Read SEC document
June 25, 2026 Filed Jun 29, 2026 20:31 UTC GrantStock Option (right to buy) · Derivative 3,837 $0.00 Strike: $64.34 $0.00
Disclosure

SEC source: 0001662426-26-000006 · wk-form4_1782765098.xml · derivative · entry 1

Morrison Scott W · CIK 0001662426 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,837

Underlying: Common Stock · 3,837 shares

Expires 2036-06-24

F1 · derivative.exercise_date: Annual option granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2026 annual meeting of stockholders. The option will vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service.

Read SEC document
June 25, 2026 Filed Jun 29, 2026 20:31 UTC GrantRestricted Stock Units · Derivative 2,417 $0.00 $0.00
Disclosure

SEC source: 0001458643-26-000004 · wk-form4_1782765084.xml · derivative · entry 2

CHAUDHURI BHASKAR · CIK 0001458643 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,417

Underlying: Common Stock · 2,417 shares

Expires not disclosed

F2 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Company's common stock.

F3 · derivative.exercise_date: RSUs granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2026 annual meeting of stockholders. The RSUs vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service.

F3 · derivative.expiration_date: RSUs granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2026 annual meeting of stockholders. The RSUs vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service.

Read SEC document
June 25, 2026 Filed Jun 29, 2026 20:31 UTC GrantStock Option (right to buy) · Derivative 3,837 $0.00 Strike: $64.34 $0.00
Disclosure

SEC source: 0001458643-26-000004 · wk-form4_1782765084.xml · derivative · entry 1

CHAUDHURI BHASKAR · CIK 0001458643 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,837

Underlying: Common Stock · 3,837 shares

Expires 2036-06-24

F1 · derivative.exercise_date: Annual option granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2026 annual meeting of stockholders. The option will vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service.

Read SEC document
June 25, 2026 Filed Jun 29, 2026 20:31 UTC GrantRestricted Stock Units · Derivative 1,209 $0.00 $0.00
Disclosure

SEC source: 0001181186-26-000006 · wk-form4_1782765069.xml · derivative · entry 3

YARNO WENDY L · CIK 0001181186 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,209

Underlying: Common Stock · 1,209 shares

Expires not disclosed

F2 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Company's common stock.

F4 · derivative.exercise_date: RSUs granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2026 annual meeting of stockholders. The RSUs vest in equal installments on 9/15/2026, 12/15/2026, 3/15/2027 and 6/15/2027, subject to the non-employee director's continuous service.

F4 · derivative.expiration_date: RSUs granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2026 annual meeting of stockholders. The RSUs vest in equal installments on 9/15/2026, 12/15/2026, 3/15/2027 and 6/15/2027, subject to the non-employee director's continuous service.

Read SEC document
June 25, 2026 Filed Jun 29, 2026 20:31 UTC GrantRestricted Stock Units · Derivative 2,417 $0.00 $0.00
Disclosure

SEC source: 0001181186-26-000006 · wk-form4_1782765069.xml · derivative · entry 2

YARNO WENDY L · CIK 0001181186 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,417

Underlying: Common Stock · 2,417 shares

Expires not disclosed

F2 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Company's common stock.

F3 · derivative.exercise_date: RSUs granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2026 annual meeting of stockholders. The RSUs vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service.

F3 · derivative.expiration_date: RSUs granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2026 annual meeting of stockholders. The RSUs vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service.

Read SEC document
June 25, 2026 Filed Jun 29, 2026 20:31 UTC GrantStock Option (right to buy) · Derivative 3,837 $0.00 Strike: $64.34 $0.00
Disclosure

SEC source: 0001181186-26-000006 · wk-form4_1782765069.xml · derivative · entry 1

YARNO WENDY L · CIK 0001181186 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,837

Underlying: Common Stock · 3,837 shares

Expires 2036-06-24

F1 · derivative.exercise_date: Annual option granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2026 annual meeting of stockholders. The option will vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service.

Read SEC document
June 25, 2026 Filed Jun 29, 2026 20:30 UTC GrantRestricted Stock Units · Derivative 806 $0.00 $0.00
Disclosure

SEC source: 0001228684-26-000008 · wk-form4_1782765039.xml · derivative · entry 3

LINK WILLIAM J PHD · CIK 0001228684 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 806

Underlying: Common Stock · 806 shares

Expires not disclosed

F2 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Company's common stock.

F4 · derivative.exercise_date: RSUs granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2026 annual meeting of stockholders. The RSUs vest in equal installments on 9/15/2026, 12/15/2026, 3/15/2027 and 6/15/2027, subject to the non-employee director's continuous service.

F4 · derivative.expiration_date: RSUs granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2026 annual meeting of stockholders. The RSUs vest in equal installments on 9/15/2026, 12/15/2026, 3/15/2027 and 6/15/2027, subject to the non-employee director's continuous service.

Read SEC document
June 25, 2026 Filed Jun 29, 2026 20:30 UTC GrantRestricted Stock Units · Derivative 2,417 $0.00 $0.00
Disclosure

SEC source: 0001228684-26-000008 · wk-form4_1782765039.xml · derivative · entry 2

LINK WILLIAM J PHD · CIK 0001228684 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,417

Underlying: Common Stock · 2,417 shares

Expires not disclosed

F2 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Company's common stock.

F3 · derivative.exercise_date: RSUs granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2026 annual meeting of stockholders. The RSUs vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service.

F3 · derivative.expiration_date: RSUs granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2026 annual meeting of stockholders. The RSUs vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service.

Read SEC document
June 25, 2026 Filed Jun 29, 2026 20:30 UTC GrantStock Option (right to buy) · Derivative 3,837 $0.00 Strike: $64.34 $0.00
Disclosure

SEC source: 0001228684-26-000008 · wk-form4_1782765039.xml · derivative · entry 1

LINK WILLIAM J PHD · CIK 0001228684 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,837

Underlying: Common Stock · 3,837 shares

Expires 2036-06-24

F1 · derivative.exercise_date: Annual option granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2026 annual meeting of stockholders. The option will vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service.

Read SEC document
June 17, 2026 Filed Jun 22, 2026 20:09 UTC
Azamian Bobak R.Director · President/CEO and Board Chair
SaleCommon Stock 5,418 $61.81 $334,886.58
Disclosure

SEC source: 0001827672-26-000009 · wk-form4_1782158996.xml · nonDerivative · entry 2

Azamian Bobak R. · CIK 0001827672 · Director · President/CEO and Board Chair

10b5-1 filing: Plan reported

Ownership: Indirect · By the Bobak Azamian Living Trust established April 16, 2018

Disclosed balance after: 847,991

F1 · kind: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 9, 2025.

F4 · price: The price reported in column 4 is a weighted average price. The shares were pooled and sold in multiple transactions at prices ranging from $61.52 to $62.13. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F3 · ownership.nature: The Reporting Person is the trustee of the Bobak Azamian Living Trust, established April 16, 2018 and has voting and dispositive power with respect to these shares.

Read SEC document
June 17, 2026 Filed Jun 22, 2026 20:09 UTC
Azamian Bobak R.Director · President/CEO and Board Chair
SaleCommon Stock 4,582 $61.24 $280,601.68
Disclosure

SEC source: 0001827672-26-000009 · wk-form4_1782158996.xml · nonDerivative · entry 1

Azamian Bobak R. · CIK 0001827672 · Director · President/CEO and Board Chair

10b5-1 filing: Plan reported

Ownership: Indirect · By the Bobak Azamian Living Trust established April 16, 2018

Disclosed balance after: 853,409

F1 · kind: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 9, 2025.

F2 · price: The price reported in column 4 is a weighted average price. The shares were pooled and sold in multiple transactions at prices ranging from $60.51 to $61.50. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F3 · ownership.nature: The Reporting Person is the trustee of the Bobak Azamian Living Trust, established April 16, 2018 and has voting and dispositive power with respect to these shares.

Read SEC document
June 16, 2026 Filed Jun 17, 2026 20:17 UTC
Farrow Jeffrey SSee Remarks
SaleCommon Stock 14,396 $60.95 $877,436.20
Disclosure

SEC source: 0001405253-26-000013 · wk-form4_1781727451.xml · nonDerivative · entry 2

Farrow Jeffrey S · CIK 0001405253 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 56,801

F2 · kind: The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.

Read SEC document
June 15, 2026 Filed Jun 17, 2026 20:17 UTC SaleCommon Stock 2,954 $62.08 $183,384.32
Disclosure

SEC source: 0002044770-26-000006 · wk-form4_1781727435.xml · nonDerivative · entry 1

Goodrich Katherine · CIK 0002044770 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 2,233

F1 · kind: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 27, 2026.

Read SEC document
June 15, 2026 Filed Jun 17, 2026 20:17 UTC
Farrow Jeffrey SSee Remarks
Exercise / conversionRestricted Stock Units · Derivative 27,881 $0.00 $0.00
Disclosure

SEC source: 0001405253-26-000013 · wk-form4_1781727451.xml · derivative · entry 3

Farrow Jeffrey S · CIK 0001405253 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 27,882

Underlying: Common Stock · 27,881 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Company's common stock.

F4 · derivative.exercise_date: RSUs granted on April 24, 2023, under the Tarsus Pharmaceuticals, Inc. 2020 Stock Plan. 25% of the RSUs will vest on June 15th of each of 2024, 2025, 2026 and 2027, subject to the Reporting Person's continuous service.

F4 · derivative.expiration_date: RSUs granted on April 24, 2023, under the Tarsus Pharmaceuticals, Inc. 2020 Stock Plan. 25% of the RSUs will vest on June 15th of each of 2024, 2025, 2026 and 2027, subject to the Reporting Person's continuous service.

Read SEC document
June 15, 2026 Filed Jun 17, 2026 20:17 UTC
Farrow Jeffrey SSee Remarks
Exercise / conversionCommon Stock 27,881 Not disclosed Not disclosed
Disclosure

SEC source: 0001405253-26-000013 · wk-form4_1781727451.xml · nonDerivative · entry 1

Farrow Jeffrey S · CIK 0001405253 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 71,197

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The shares were issued pursuant to settlement of vested Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Company's common stock.

F1 · price: The shares were issued pursuant to settlement of vested Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Company's common stock.

Read SEC document
June 15, 2026 Filed Jun 17, 2026 20:17 UTC SaleCommon Stock 1,928 $62.94 $121,348.32
Disclosure

SEC source: 0001228684-26-000006 · wk-form4_1781727420.xml · nonDerivative · entry 2

LINK WILLIAM J PHD · CIK 0001228684 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 106,786

F1 · kind: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 8, 2025.

F3 · price: The price reported in column 4 is a weighted average price. The shares were pooled and sold in multiple transactions at prices ranging from $62.68 to $63.05. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
June 15, 2026 Filed Jun 17, 2026 20:17 UTC SaleCommon Stock 10,572 $61.97 $655,146.84
Disclosure

SEC source: 0001228684-26-000006 · wk-form4_1781727420.xml · nonDerivative · entry 1

LINK WILLIAM J PHD · CIK 0001228684 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 108,714

F1 · kind: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 8, 2025.

F2 · price: The price reported in column 4 is a weighted average price. The shares were pooled and sold in multiple transactions at prices ranging from $61.67 to $62.67. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
June 12, 2026 Filed Jun 16, 2026 20:05 UTC Exercise / conversionRestricted Stock Units · Derivative 2,954 $0.00 $0.00
Disclosure

SEC source: 0002044770-26-000004 · wk-form4_1781640353.xml · derivative · entry 2

Goodrich Katherine · CIK 0002044770 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,954 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Company's common stock.

F3 · derivative.exercise_date: RSUs granted on June 12, 2025, in connection with the Reporting Person's service as a non-employee director as of the Company's 2025 annual meeting of stockholders. The RSUs will vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service.

F3 · derivative.expiration_date: RSUs granted on June 12, 2025, in connection with the Reporting Person's service as a non-employee director as of the Company's 2025 annual meeting of stockholders. The RSUs will vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service.

Read SEC document
June 12, 2026 Filed Jun 16, 2026 20:05 UTC Exercise / conversionCommon Stock 2,954 Not disclosed Not disclosed
Disclosure

SEC source: 0002044770-26-000004 · wk-form4_1781640353.xml · nonDerivative · entry 1

Goodrich Katherine · CIK 0002044770 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,187

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The shares were issued pursuant to settlement of vested Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Company's common stock.

F1 · price: The shares were issued pursuant to settlement of vested Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Company's common stock.

Read SEC document
June 12, 2026 Filed Jun 16, 2026 20:06 UTC Exercise / conversionRestricted Stock Units · Derivative 2,954 $0.00 $0.00
Disclosure

SEC source: 0001662426-26-000004 · wk-form4_1781640402.xml · derivative · entry 3

Morrison Scott W · CIK 0001662426 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,954 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Company's common stock.

F4 · derivative.exercise_date: RSUs granted on June 12, 2025, in connection with the Reporting Person's service as a non-employee director as of the Company's 2025 annual meeting of stockholders. The RSUs will vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service.

F4 · derivative.expiration_date: RSUs granted on June 12, 2025, in connection with the Reporting Person's service as a non-employee director as of the Company's 2025 annual meeting of stockholders. The RSUs will vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service.

Read SEC document
June 12, 2026 Filed Jun 16, 2026 20:06 UTC Exercise / conversionCommon Stock 2,954 Not disclosed Not disclosed
Disclosure

SEC source: 0001662426-26-000004 · wk-form4_1781640402.xml · nonDerivative · entry 1

Morrison Scott W · CIK 0001662426 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,638

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The shares were issued pursuant to settlement of vested Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Company's common stock.

F1 · price: The shares were issued pursuant to settlement of vested Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Company's common stock.

Read SEC document
June 12, 2026 Filed Jun 16, 2026 20:06 UTC Exercise / conversionRestricted Stock Units · Derivative 2,954 $0.00 $0.00
Disclosure

SEC source: 0001228684-26-000004 · wk-form4_1781640385.xml · derivative · entry 2

LINK WILLIAM J PHD · CIK 0001228684 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,954 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Company's common stock.

F3 · derivative.exercise_date: RSUs granted on June 12, 2025, in connection with the Reporting Person's service as a non-employee director as of the Company's 2025 annual meeting of stockholders. The RSUs will vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service.

F3 · derivative.expiration_date: RSUs granted on June 12, 2025, in connection with the Reporting Person's service as a non-employee director as of the Company's 2025 annual meeting of stockholders. The RSUs will vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.